Cockcroft D W
University of Saskatchewan, Saskatoon, Canada.
Can Respir J. 1998 Jul-Aug;5 Suppl A:14A-7A.
The understanding of how inhaled allergens affect the asthmatic patient has changed significantly over the years. Allergen inhalation was first recognized as a cause of asthma in 1873, and the clinically important late asthmatic response (LAR) was demonstrated, albeit crudely, in 1952. Immunopathogenesis of the LAR was controversial until the 1970s when it was demonstrated conclusively that allergen-induced late cutaneous response and LAR are immunoglobulin E dependent. Hargreave and colleagues were first to identify nonallergic airway hyper-responsiveness, a consistent feature of all types of asthma, as one important determinant of airway response to inhaled allergens. More important, airway responsiveness was shown to increase following an allergen exposure, primarily in association with the LAR. Inhaled allergens could now be recognized not as one of numerous stimuli triggering symptoms in asthmatics, but as a fundamentally more important stimulus that causes airway responsiveness and, as subsequent investigations showed, airway inflammation. This led to the important recognition that allergens are actually 'causes' of asthma.
多年来,人们对吸入性过敏原如何影响哮喘患者的理解发生了显著变化。1873年,吸入过敏原首次被确认为哮喘的一个病因,1952年,临床上重要的迟发性哮喘反应(LAR)被证实,尽管方式较为粗略。直到20世纪70年代,LAR的免疫发病机制一直存在争议,当时有确凿证据表明,过敏原诱导的迟发性皮肤反应和LAR是依赖免疫球蛋白E的。哈格里夫斯及其同事首先发现了非过敏性气道高反应性,这是所有类型哮喘的一个一致特征,是气道对吸入性过敏原反应的一个重要决定因素。更重要的是,研究表明,过敏原暴露后气道反应性会增加,主要与迟发性哮喘反应相关。现在可以认识到,吸入性过敏原并非引发哮喘患者症状的众多刺激因素之一,而是一种从根本上来说更为重要的刺激因素,它会导致气道反应性增加,而且后续研究表明,还会导致气道炎症。这使得人们重要地认识到,过敏原实际上是哮喘的“病因”。